FIELD: molecular biology, pharmacology. SUBSTANCE: composition is a liposomal vesicle containing a protein preparation. Liposome is one of phospholipids and protein is a hemopoietic factor, in part, cytokin, G-CSF, or GM-CSF. Invention describes also a method of preparing a composition at pH = 3.0-7.5 at ratio of lipid to protein = 10:1, not less. EFFECT: broadened pattern of liposomal forms of drugs. 23 cl, 19 dwg, 1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION LIPOSOMAL COMPOSITIONS FOR CANCER TREATMENT | 2012 |
|
RU2640934C2 |
| LIPOSOMAL COMPOSITIONS APPLICABLE FOR DRUG DELIVERY | 2005 |
|
RU2574926C2 |
| PROLONGED RELEASE OF ANTI-INFECTIOUS AGENTS | 2006 |
|
RU2438655C2 |
| PHARMACEUTICAL COMPOSITION FOR TREPOSTINIL CONTROLLED RELEASE | 2019 |
|
RU2796305C2 |
| STABILISED VANCOMYCIN FORMULATIONS | 2013 |
|
RU2675859C2 |
| PHARMACEUTICAL COMPOSITIONS TO REDUCE COMPLICATIONS OF OCULAR STEROID | 2013 |
|
RU2660585C2 |
| STABLE COMPOSITIONS OF LIPIDS AND LIPOSOMES | 2015 |
|
RU2738060C2 |
| LIPOSOMAL COMPOSITIONS CONTAINING SLIGHTLY ACIDIC DRUGS, AND THEIR USE | 2018 |
|
RU2778886C2 |
| PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF WEAK ACID DRUGS AND ITS USE | 2019 |
|
RU2810790C2 |
| LIPOSOMAL COMPOSITION AND METHOD OF OBTAINING THEREOF | 2011 |
|
RU2577683C2 |
